KRAS and non-small cell lung carcinoma: Indeed, we previously found that enhanced activity of the acyl-CoA synthetase long-chain 3 (ACSL3), an enzyme that catalyzes the activation of long-chain fatty acids to CoA thioesters, boosts extracellularly derived fatty acid activation in mutant KRAS NSCLC [17].